SYRE Spyre Therapeutics, Inc.

Fundamentals / CIK 0001636282 / USD

Spyre Therapeutics, Inc. reported $0 in revenue and a net loss of $263.9M for the fiscal year ended December 31, 2025.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SYRE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$54.25M$27.12M$0-$318.4MFY 2016 Revenue: $4.63MFY 2016 Net Income: -$21.70M2016FY 2017 Revenue: $5.21MFY 2017 Net Income: -$27.24M2017FY 2018 Revenue: $3.89MFY 2018 Net Income: -$44.35M2018FY 2019 Revenue: $0FY 2019 Net Income: -$78.25M2019FY 2020 Revenue: $0FY 2020 Net Income: -$80.89M2020FY 2021 Revenue: $18.74MFY 2021 Net Income: -$65.80M2021FY 2022 Revenue: $2.33MFY 2022 Net Income: -$83.81M2022FY 2023 Revenue: $886KFY 2023 Net Income: -$338.8M2023FY 2024 Revenue: $0FY 2024 Net Income: -$208.0M2024FY 2025 Revenue: $0FY 2025 Net Income: -$155.2M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 $886K $2.33M $18.74M $0 $0 $3.89M $5.21M $4.63M
Research & Development $171.7M $162.8M $89.50M $58.58M $57.07M $59.64M $64.60M $36.72M $22.82M $18.14M
Total Operating Expenses $209.6M $208.6M $243.2M $87.11M $84.39M $81.48M $80.33M $49.35M $32.88M $26.53M
Operating Income -$209.6M -$208.6M -$242.3M -$84.78M -$65.65M -$81.48M -$80.33M -$45.46M -$27.68M -$21.91M
EBITDA -$209.6M -$208.6M -$241.6M -$83.21M -$64.07M -$80.48M -$79.92M -$45.17M -$27.43M -$21.77M
Income Before Tax -$155.2M -$208.0M -$338.8M -$83.95M -$65.66M -$80.89M -$78.25M -- -- --
Income Tax Expense -$15K $51K -$26K -$136K $141K $0 $0 $0 $0 $0
Net Income -$155.2M -$208.0M -$338.8M -$83.81M -$65.80M -$80.89M -$78.25M -$44.35M -$27.24M -$21.70M
Basic EPS -- -- -$49.12 -$24.86 -$25.02 -$38.00 -$61.25 -$53.25 -$45.00 -$55.50
Diluted EPS -- -- -$49.12 -$24.86 -$25.02 -$38.00 -$61.25 -$53.25 -$45.00 -$55.50
Basic Shares Outstanding -- -- 6.9M 3.4M 2.6M 2.1M 1.3M 832.9K 605.1K 391.7K
Diluted Shares Outstanding -- -- 6.9M 3.4M 2.6M 2.1M 1.3M 832.9K 605.1K 391.7K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- -- -- -- $0
Research & Development $89.17M $65.50M $60.41M $44.64M $45.25M $40.15M $41.62M $50.48M
Total Operating Expenses $105.7M $41.64M $45.64M $57.17M $56.89M $41.94M $53.57M $61.25M
Operating Income -$105.7M -$41.64M -$45.64M -$57.17M -$56.89M -$41.94M -$53.57M -$61.25M
EBITDA -- -- -- -- -- -- -- -$61.25M
Income Before Tax -$96.12M -$36.20M -$69.00M -$62.53M -$11.18M -$36.72M -$44.79M -$56.30M
Income Tax Expense $0 $0 $0 $0 $0 $0 -$15K $1.0K
Net Income -$96.12M -$36.20M -$69.00M -$62.53M -$11.18M -$36.72M -$44.77M -$56.30M
Diluted EPS -- -- -$0.74 -- -- -- -- --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $85.72M $89.42M $188.9M $34.86M $15.14M $90.09M $19.25M $22.46M $12.82M $47.75M
Short-Term Investments $670.8M $513.7M $150.4M $20.85M $77.99M $56.18M $52.70M $52.05M $37.48M $15.75M
Cash & Short-Term Investments $756.5M $603.1M $339.3M $55.71M $93.13M $146.3M $71.95M $74.50M $50.30M $63.50M
Total Current Assets $777.8M $608.5M $341.5M $62.26M $98.89M $149.8M $74.50M $76.67M $54.99M $66.42M
Property, Plant & Equipment, Net -- -- $0 $3.22M $4.55M $5.64M $2.38M $1.02M $854K $599K
Other Non-Current Assets $0 $10K $9.0K $683K $842K $115K $67K $50K $232K $40K
Total Non-Current Assets $0 $10K $331K $8.89M $11.04M $11.83M $8.68M $1.07M $1.09M $639K
Total Assets $777.8M $608.5M $341.9M $71.14M $109.9M $161.6M $83.18M $77.74M $56.08M $67.06M
Accounts Payable -- -- $896K $677K $3.32M $2.25M $3.15M $663K $389K $168K
Deferred Revenue (Current) -- -- $0 $517K $3.58M $0 -- -- $20K $71K
Total Current Liabilities $58.69M $54.06M $31.98M $14.66M $20.14M $16.44M $18.36M $10.24M $5.63M $3.96M
Deferred Revenue (Non-Current) -- -- $0 $2.18M $1.22M $0 -- -- -- --
Other Non-Current Liabilities $0 -- -- $0 $16K $214K $31K $72K $111K $132K
Total Non-Current Liabilities $3.86M $36.62M $41.31M $6.18M $5.84M $5.34M $4.74M $72K $111K $132K
Total Liabilities $62.55M $90.68M $73.29M $20.84M $25.98M $21.79M $23.10M $10.31M $5.74M $4.10M
Total Debt (incl. Leases) -- -- -- $4.64M $5.48M $5.52M $5.12M -- -- --
Common Stock $15K $13K $10K $6.0K $5.0K $5.0K $3.0K $2.0K $2.0K $1.0K
Retained Earnings -$1.13B -$972.4M -$764.4M -$425.6M -$341.8M -$276.0M -$195.1M -$116.9M -$72.51M -$45.28M
Accumulated Other Comp. Income $869K $180K $302K -$48K -$20K $11K $51K -$27K -$102K -$4.0K
Total Stockholders' Equity $715.2M $517.8M $184.0M $50.30M $83.94M $139.8M $60.08M $67.43M $50.34M $62.97M
Total Equity $715.2M $517.8M $184.0M $50.30M $83.94M $139.8M $60.08M $67.43M $50.34M $62.97M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $82.73M $162.0M $97.19M $85.72M $64.90M $81.66M $48.49M $89.42M
Short-Term Investments $989.2M $983.3M $644.3M $670.8M $421.3M $444.9M $516.3M $513.7M
Cash & Short-Term Investments $1.10B $1.10B $741.5M $756.5M $486.2M $526.6M $564.8M $603.1M
Total Current Assets $1.10B $1.17B $764.0M $777.8M $504.6M $538.8M $569.8M $608.5M
Other Non-Current Assets -- -- -- $0 $0 $0 $10K $10K
Total Non-Current Assets $0 $0 $0 $0 $0 $0 $10K $10K
Total Assets $1.10B $1.17B $764.0M $777.8M $504.6M $538.8M $569.8M $608.5M
Total Current Liabilities $40.14M $63.30M $85.16M $58.69M $46.27M $83.06M $70.68M $54.06M
Other Non-Current Liabilities $1.29M $1.29M $1.29M $0 -- -- -- --
Total Non-Current Liabilities $8.05M $8.56M $7.98M $3.86M $3.23M $0 $16.49M $36.62M
Total Liabilities $48.19M $71.86M $93.14M $62.55M $49.50M $83.06M $87.17M $90.68M
Common Stock $16K $16K $15K $15K $13K $13K $13K $13K
Retained Earnings -$1.33B -$1.23B -$1.20B -$1.13B -$1.07B -$1.05B -$1.02B -$972.4M
Accumulated Other Comp. Income -$5.38M -$2.40M -$767K $869K $791K $454K $682K $180K
Total Stockholders' Equity $1.05B $1.10B $670.8M $715.2M $455.1M $455.8M $482.6M $517.8M
Total Equity $1.05B $1.10B $670.8M $715.2M $455.1M $455.8M $482.6M $517.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$155.2M -$208.0M -$338.8M -$83.81M -$65.80M -$80.89M -$78.25M -$44.35M -$27.24M -$21.70M
Depreciation & Amortization $0 $0 $744K $1.57M $1.58M $996K $418K $293K $249K $132K
Stock-Based Compensation $37.61M $44.83M $25.68M $7.11M $8.04M $6.26M $4.88M $4.28M $2.49M $1.22M
Change in Receivables $0 $0 $375K $440K -$815K $0 $0 $3.08M -$1.86M $482K
Change in Payables $8.24M -$230K $218K -$2.64M $1.06M -$544K $2.58M $239K $164K -$8.0K
Operating Cash Flow -$169.3M -$157.4M -$99.91M -$80.14M -$53.72M -$75.78M -$65.69M -$32.19M -$24.61M -$18.84M
Capital Expenditure -- $0 $0 -$38K -$573K -$4.28M -$1.49M -$422K -$619K -$212K
Free Cash Flow -- -$157.4M -$99.91M -$80.18M -$54.29M -$80.06M -$67.18M -$32.62M -$25.23M -$19.05M
Purchases of Investments -$522.2M -$599.3M -$166.8M -$39.50M -$133.1M -$129.0M -$91.93M -$62.18M -$64.11M -$20.39M
Investing Cash Flow -$143.5M -$353.3M -$108.4M $57.01M -$22.62M -$7.60M -$1.74M -$15.23M -$22.53M -$12.08M
Common Stock Issued -- -- $84.56M $0 $0 -- -- -- -- $76K
Financing Cash Flow $309.0M $410.9M $361.1M $42.68M $1.39M $154.5M $65.72M $57.07M $12.21M $49.37M
Net Change in Cash -$3.70M -$99.79M $152.8M $19.44M -$74.96M $71.18M -$1.71M $9.64M -$34.93M $18.45M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$96.12M -$36.20M -$69.00M -$62.53M -$11.18M -$36.72M -$44.77M -$56.30M
Depreciation & Amortization -- -- -- -- -- -- -- $0
Stock-Based Compensation $14.17M $13.51M $12.81M $9.81M $9.57M $9.38M $8.86M $9.22M
Change in Receivables -- -- -- -- -- -- -- $0
Change in Payables $3.74M $30K -$3.21M $1.45M $3.75M $23K $3.02M -$4.50M
Operating Cash Flow -$77.50M -$69.88M -$57.37M -$44.58M -$37.12M -$46.56M -$40.99M -$37.20M
Purchases of Investments -$138.3M -$447.3M -$81.17M -$341.7M -$74.19M -$34.87M -$71.44M -$233.1M
Investing Cash Flow -$3.80M -$297.9M $56.58M -$247.4M $25.00M $79.00M -$61K -$170.5M
Financing Cash Flow $2.02M $432.6M $12.26M $312.8M -$4.64M $731K $125K $225.6M
Net Change in Cash -$79.28M $64.82M $11.46M $20.82M -$16.76M $33.17M -$40.93M $17.84M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -27348.0% -3640.2% -350.3% -- -- -1169.3% -531.7% -473.3%
Net Profit Margin -- -- -38238.1% -3598.8% -351.1% -- -- -1140.6% -523.3% -468.8%
Return on Equity (ROE) -21.7% -40.2% -184.1% -166.6% -78.4% -57.9% -130.2% -65.8% -54.1% -34.5%
Return on Assets (ROA) -20.0% -34.2% -99.1% -117.8% -59.9% -50.1% -94.1% -57.0% -48.6% -32.4%
Current Ratio 13.25x 11.26x 10.68x 4.25x 4.91x 9.11x 4.06x 7.49x 9.77x 16.75x
Quick Ratio 12.89x 11.16x 10.61x 3.80x 4.62x 8.90x 3.92x 7.28x 8.94x 16.02x
Debt to Equity -- -- -- 0.09x 0.07x 0.04x 0.09x -- -- --
Revenue Growth (YoY) -- -100.0% -62.0% -87.6% -- -- -100.0% -25.3% +12.5% --
5Y Revenue / Share Growth -- -- -97.2% -92.0% -39.7% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -25.1% -16.2% -26.7% -21.7% -32.7% -45.4% -43.3% -40.2%
Return on Assets (ROA) -24.0% -15.3% -23.5% -20.0% -29.5% -38.4% -36.7% -34.2%
Current Ratio 27.40x 18.53x 8.97x 13.25x 10.90x 6.49x 8.06x 11.26x
Quick Ratio 27.40x 17.38x 8.71x 12.89x 10.51x 6.34x 7.99x 11.16x
Source: SEC EDGAR CompanyFacts (CIK 0001636282) · from December 31, 2014 Data through September 30, 2026 · synced Nov 20, 2026, 05:10 UTC · Open in terminal